NCT01668680View on ClinicalTrials.gov

Maintenance Metronomic Chemotherapy for Metastatic Colorectal Carcinoma

PHASE2TerminatedINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2014

Conditions

Colorectal Cancer Metastatic

Interventions

DRUG

CAPECITABINE, CELECOXIB and METHOTREXATE

daily oral treatment with CAPECITABINE, CELECOXIB and METHOTREXATE

Trial Locations (1)

18101

HaEmek Medical Center, Afula

Sponsors

Collaborators (1)

Clalit Health Services

All Listed Sponsors

collaborator

Clalit Health Services

OTHER

lead

HaEmek Medical Center, Israel

OTHER